Biopharmaceutical R&D outsourcing: Short-term ...
Type de document :
Article dans une revue scientifique: Article original
Titre :
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?
Auteur(s) :
Scannell, Jack [Auteur]
Science, Technology and Innovation Studies Subject Group [Edinburgh]
Versaevel, Bruno [Auteur]
EMLyon Business School [EM]
Billette De Villemeur, Etienne [Auteur]
Lille économie management - UMR 9221 [LEM]
Science, Technology and Innovation Studies Subject Group [Edinburgh]
Versaevel, Bruno [Auteur]
EMLyon Business School [EM]
Billette De Villemeur, Etienne [Auteur]

Lille économie management - UMR 9221 [LEM]
Titre de la revue :
Drug discovery today
Pagination :
103333
Éditeur :
Elsevier
Date de publication :
2022-11
ISSN :
1359-6446
Mot(s)-clé(s) en anglais :
Research
Development
Biotechnology
Pharmaceuticals
Externalities
Outsourcing
Development
Biotechnology
Pharmaceuticals
Externalities
Outsourcing
Discipline(s) HAL :
Sciences de l'Homme et Société/Economies et finances
Résumé en anglais : [en]
Research and development (R&D) outsourcing offers some obvious productivity benefits (e.g., access to new technology, variabilised costs, risk sharing, etc.). However, recent work in economics points to a productivity ...
Lire la suite >Research and development (R&D) outsourcing offers some obvious productivity benefits (e.g., access to new technology, variabilised costs, risk sharing, etc.). However, recent work in economics points to a productivity headwind at the level of the innovation ecosystem. The market for technologies with economies of scope and knowledge spillovers (those with the biggest impact on industry economics and social welfare) has structural features that allow customers to capture a disproportionate share of economic value and transfer a disproportionate share of economic risk to technology providers, even though the providers aim to maximise profit. This reduces the incentives to invest in new ventures that specialise in the most promising early-stage projects. Therefore, near-term gains from R&D outsourcing can be offset by slower innovation in the long run.Lire moins >
Lire la suite >Research and development (R&D) outsourcing offers some obvious productivity benefits (e.g., access to new technology, variabilised costs, risk sharing, etc.). However, recent work in economics points to a productivity headwind at the level of the innovation ecosystem. The market for technologies with economies of scope and knowledge spillovers (those with the biggest impact on industry economics and social welfare) has structural features that allow customers to capture a disproportionate share of economic value and transfer a disproportionate share of economic risk to technology providers, even though the providers aim to maximise profit. This reduces the incentives to invest in new ventures that specialise in the most promising early-stage projects. Therefore, near-term gains from R&D outsourcing can be offset by slower innovation in the long run.Lire moins >
Langue :
Anglais
Comité de lecture :
Oui
Audience :
Internationale
Vulgarisation :
Non
Collections :
Source :
Fichiers
- j.drudis.2022.08.001
- Accès libre
- Accéder au document